Concepedia

Maria Jure‐Kunkel

MJ

Statistics

Publications

18

Citations

1.1K

H-Index

14

Active since

2001

Affiliations

Bristol-Myers Squibb (United States)(Current)

Clinica Universidad de Navarra

Bristol-Myers Squibb (Germany)

Universidad de Navarra

Genmab (Netherlands)

Maria Jure‐Kunkel is an author at Bristol-Myers Squibb (United States) specializing in immunology, oncology, and cancer immunotherapy.

ORCID

Publications per year

2001–2025

18

Publications

18

Agonist Anti-CD137 mAb Act on Tumor Endothelial Cells to Enhance Recruitment of Activated T Lymphocytes

Asís Palazón, Álvaro Teijeira, Iván Martínez‐Forero et al. · Cancer Research · 2011 · 138 citations

, , +17

Paradoxical Activation of T Cells via Augmented ERK Signaling Mediated by a RAF Inhibitor

Margaret K. Callahan, Gregg Masters, Christine A. Pratilas et al. · Cancer Immunology Research · 2013 · 120 citations · Full text

, , +17

Inhibition of angiogenesis and metastasis in two murine models by the matrix metalloproteinase inhibitor, BMS-275291.

Joseph G. Naglich, Maria Jure‐Kunkel, Elora Gupta et al. · PubMed · 2001 · 114 citations

, , +12

Preclinical Characterization and Phase I Trial Results of a Bispecific Antibody Targeting PD-L1 and 4-1BB (GEN1046) in Patients with Advanced Refractory Solid Tumors

Alexander Muik, Elena Garralda, Friederike Gieseke et al. · Cancer Discovery · 2022 · 113 citations · Full text

, , +17

Anti-CD137 Monoclonal Antibody Administration Augments the Antitumor Efficacy of Dendritic Cell-Based Vaccines

Fumito Ito, Qiao Li, Andrew B. Shreiner et al. · Cancer Research · 2004 · 109 citations · Full text

, , +17

1–5 of 18